Injectables
Neuromodulators in Montréal: Five Common Misconceptions
Answers to common questions about neuromodulators, natural expression and duration, from Le RoseWood Journal in Montréal.
Few aesthetic treatments carry as much folklore as neuromodulators. Most of the hesitation we hear in consultations comes from a handful of ideas that circulate widely but do not hold up. Here are the five we correct most often, and what the evidence actually says.
Misconception 1: "It's all called Botox"
Botox is one brand name. The aesthetic neuromodulators discussed here are products based on botulinum toxin type A, and several brands exist. In this journal we usually refer to the treatment class rather than a single brand. The specific product, your anatomy, the dose, and the placement all matter, and doses are not interchangeable between products.
Misconception 2: "If I stop, my wrinkles will come back worse"
No. A neuromodulator temporarily reduces the activity of the treated muscle. When treatment is stopped, the muscle simply returns to moving the way it did before, and lines gradually return to their pre-treatment state. Nothing in the published evidence suggests that stopping makes wrinkles worse than they would have been without treatment. A Cochrane review confirms that the effect of botulinum toxin type A is temporary, with muscle activity returning over the following months (Camargo et al., 2021).
Misconception 3: "It makes you age faster"
The reasoning runs in the opposite direction. Many etched-in lines form because the same muscle creases the same skin thousands of times. Softening that repetitive movement means less mechanical folding of the skin over time, which is why some people use neuromodulators partly as a way to slow the deepening of expression lines. This is a reasonable expectation, not a promise: long-term preventative benefit has not been definitively proven, and the Cochrane authors note that evidence on long-term and repeated use is still limited (Camargo et al., 2021).
Misconception 4: "It lasts six months"
For most people the visible effect lasts closer to three or four months, though the honest answer is that it varies. The area treated, the dose, your metabolism, and how expressive you are all play a role. Some people metabolize treatment faster; some areas, like the masseters, behave differently from the forehead (Ferrillo et al., 2025). We plan around your response, not around a fixed calendar.
Misconception 5: "It freezes your whole face"
An overly restricted expression can reflect the treatment plan, including product, dose, and placement, as well as individual anatomy and response. A conservative, personalized plan aims to soften lines while preserving natural expression, but no specific outcome can be guaranteed. Assessing movement before treatment is an important part of that plan.
Bring your questions to a consultation
Neuromodulators are among the most studied treatments in aesthetic medicine. The Cochrane review found them effective for facial wrinkles within four weeks, with eyelid drooping the main significant risk reported (Camargo et al., 2021). If questions or old myths have been holding you back, bring them to a consultation. We will answer all of them before anything is decided.
Related services
Read next
Under-Eye Concerns in Montréal: Dark Circles, Fine Lines and Puffiness
Understand the differences between pigment, hollowing, fine lines and puffiness, and what an under-eye consultation in Montréal can clarify.
Collagen and Skin Firmness in Montréal: What to Know
A simple guide to collagen, gradual skin changes and the treatment options discussed at Le RoseWood in Montréal.
Skin Boosters in Montréal: Hydration and Skin Quality
What hyaluronic acid skin boosters can offer, their limits and how suitability is assessed during a Montréal consultation.
Consult in Montréal
A personalized consultation at Clinique Le RoseWood in Montréal.
108 Chemin de la Pointe N, Montréal, QC H3E 0E3
Book a consultationReferences
- Camargo, C. P., Xia, J., Costa, C. S., Gemperli, R., Tatini, M. D. C., Bulsara, M. K., & Riera, R. (2021). Botulinum toxin type A for facial wrinkles. Cochrane Database of Systematic Reviews, (7), Article CD011301. https://doi.org/10.1002/14651858.CD011301.pub2
- Ferrillo, M., Sommadossi, E., Raciti, L., Calafiore, D., Mezian, K., Tarantino, V., Vecchio, M., Longo, U. G., Losco, L., & de Sire, A. (2025). The role of botulinum toxin for masseter muscle hypertrophy: A comprehensive review. Toxins, 17(2), Article 91. https://doi.org/10.3390/toxins17020091